{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:53:14Z","timestamp":1794981194128,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["498383"],"award-info":[{"award-number":["498383"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Healthy neurodevelopment requires adequate folates (vitamin B9), which are critical for key biosynthetic and homeostatic processes in the central nervous system (CNS). In the brain, folate transport is mediated by three major pathways: folate receptor alpha (FR\u03b1), proton-coupled folate transporter (PCFT), and reduced folate carrier (RFC). Folate uptake primarily occurs at the blood-cerebrospinal fluid barrier (BCSFB) by concerted actions of FR\u03b1 and PCFT. Alterations in this transport pathway can result in cerebral folate deficiency (CFD), a rare but devastating pediatric condition associated with neuroinflammation and oxidative stress. Recent findings highlight the blood-brain barrier (BBB) as an alternative route for folate delivery, particularly through RFC upregulation. We hypothesized that pyrroloquinoline quinone (PQQ), an activator of nuclear respiratory factor 1 (NRF-1) and PGC-1\u03b1, key regulators of mitochondrial biogenesis, could enhance RFC expression at the BBB and mitigate CFD-induced damage. Using <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> models of folate deficiency, we investigated its impact on BBB integrity, inflammation, oxidative stress, mitochondrial dysfunction, and assessed PQQ\u2019s ability to reverse these effects. Human brain microvessel endothelial cells (hCMEC\/D3) cultured in control folate-sufficient (FS) or folate-deficient (FD) medium were treated with PQQ (1 or 5 \u00b5M) or vehicle control for 24\u00a0h. Wildtype (C57BL6\/N) mice received FD (0\u00a0mg\/kg folate), or FS (2\u00a0mg\/kg folate) diet and underwent a 10-day (20\u00a0mg\/kg\/day, i.p) PQQ treatment. Following treatment, hCMEC\/D3 cells and isolated mouse brain capillaries were analyzed using qPCR, ELISA, and immunoblotting to assess gene and protein expression of tight junction proteins, inflammatory and oxidative stress markers, mitochondrial transcription factors, and folate transporters. BBB permeability was evaluated <jats:italic>in vivo<\/jats:italic> using the sodium fluorescein (NaFl) assay. FD significantly increased the gene and\/or protein expression of inflammatory cytokines\/chemokines, endothelial adhesion molecules and oxidative stress markers, while tight junction proteins were significantly downregulated both in vitro and in vivo. The NaFl assay confirmed increased BBB permeability in FD mice. PQQ treatment effectively reversed these changes by upregulating RFC and PCFT expression, restoring BBB permeability, mitigating inflammatory and oxidative stress responses and improving mitochondrial biogenesis via PGC-1\u03b1\/NRF-1 signaling. These results highlight the impact of brain FD on BBB integrity, potentially contributing to neurological deficits seen in CFD disorders with PQQ providing a promising therapeutic strategy.<\/jats:p>","DOI":"10.1186\/s12987-025-00689-y","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:12:20Z","timestamp":1753182740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuroprotective role of pyrroloquinoline quinone in folate deficiency-induced blood-brain barrier disruption"],"prefix":"10.1186","volume":"22","author":[{"given":"Sara","family":"Aboulhassane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sangha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Tozammel","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"3","key":"689_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1081\/CRP-100108171","volume":"18","author":"C Wagner","year":"2001","unstructured":"Wagner C. Biochemical role of folate in cellular metabolism. Clin Res Regul Affairs. 2001;18(3):161\u201380. https:\/\/doi.org\/10.1081\/CRP-100108171.","journal-title":"Clin Res Regul Affairs"},{"key":"689_CR2","doi-asserted-by":"publisher","unstructured":"Bailey LB, Rampersaud GC, Kauwell GPA. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr. 2003;133(6). https:\/\/doi.org\/10.1093\/jn\/133.6.1961S. 1961S-1968S.","DOI":"10.1093\/jn\/133.6.1961S"},{"key":"689_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2016.00080","volume":"10","author":"RE Frye","year":"2016","unstructured":"Frye RE, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros E. Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups. Front Neurosci. 2016;10:80. https:\/\/doi.org\/10.3389\/fnins.2016.00080.","journal-title":"Front Neurosci"},{"issue":"1","key":"689_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0969-9961(03)00070-6","volume":"14","author":"PI Ho","year":"2003","unstructured":"Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis. 2003;14(1):32\u201342. https:\/\/doi.org\/10.1016\/S0969-9961(03)00070-6.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"689_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/cge.13421","volume":"95","author":"C Lintas","year":"2019","unstructured":"Lintas C. Linking genetics to epigenetics: the role of folate and folate-Related pathways in neurodevelopmental disorders. Clin Genet. 2019;95(2):241\u201352. https:\/\/doi.org\/10.1111\/cge.13421.","journal-title":"Clin Genet"},{"key":"689_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0083-6729(03)01012-4","volume":"66","author":"LH Matherly","year":"2003","unstructured":"Matherly LH, Goldman DI. Membrane transport of folates. Vitam Horm. 2003;66:403\u201356. https:\/\/doi.org\/10.1016\/s0083-6729(03)01012-4.","journal-title":"Vitam Horm"},{"key":"689_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-nutr-072610-145133","volume":"31","author":"R Zhao","year":"2011","unstructured":"Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. 2011;31:177\u2013201. https:\/\/doi.org\/10.1146\/annurev-nutr-072610-145133.","journal-title":"Annu Rev Nutr"},{"key":"689_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mam.2016.09.002","volume":"53","author":"R Zhao","year":"2017","unstructured":"Zhao R, Aluri S, Goldman ID. The Proton-Coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: hereditary folate malabsorption. Mol Aspects Med. 2017;53:57\u201372. https:\/\/doi.org\/10.1016\/j.mam.2016.09.002.","journal-title":"Mol Aspects Med"},{"key":"689_CR9","doi-asserted-by":"publisher","unstructured":"Zhao R, Goldman ID, Folate. Thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors. Mol Aspects Med. 2013;34(2):373\u201385. https:\/\/doi.org\/10.1016\/j.mam.2012.07.006.","DOI":"10.1016\/j.mam.2012.07.006"},{"issue":"8","key":"689_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","volume":"56","author":"BA Kamen","year":"2004","unstructured":"Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-Methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 2004;56(8):1085\u201397. https:\/\/doi.org\/10.1016\/j.addr.2004.01.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"689_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tips.2020.02.004","volume":"41","author":"C Alam","year":"2020","unstructured":"Alam C, Kondo M, O\u2019Connor DL, Bendayan R. Clinical implications of folate transport in the central nervous system. Trends Pharmacol Sci. 2020;41(5):349\u201361. https:\/\/doi.org\/10.1016\/j.tips.2020.02.004.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"689_CR12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/ncomms3123","volume":"4","author":"M Grapp","year":"2013","unstructured":"Grapp M, Wrede A, Schweizer M, H\u00fcwel S, Galla H-J, Snaidero N, Simons M, B\u00fcckers J, Low PS, Urlaub H, G\u00e4rtner J, Steinfeld R. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun. 2013;4(1):2123. https:\/\/doi.org\/10.1038\/ncomms3123.","journal-title":"Nat Commun"},{"issue":"7","key":"689_CR13","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1074\/jbc.M807665200","volume":"284","author":"R Zhao","year":"2009","unstructured":"Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman I. D. A role for the Proton-Coupled folate transporter (PCFT-SLC46A1) in folate Receptor-Mediated endocytosis. J Biol Chem. 2009;284(7):4267\u201374. https:\/\/doi.org\/10.1074\/jbc.M807665200.","journal-title":"J Biol Chem"},{"issue":"15","key":"689_CR14","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3390\/nu14153096","volume":"14","author":"VT Ramaekers","year":"2022","unstructured":"Ramaekers VT, Quadros EV. Cerebral folate deficiency syndrome: early diagnosis, intervention and treatment strategies. Nutrients. 2022;14(15):3096. https:\/\/doi.org\/10.3390\/nu14153096.","journal-title":"Nutrients"},{"issue":"19","key":"689_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMoa043160","volume":"352","author":"VT Ramaekers","year":"2005","unstructured":"Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, Selhub J. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352(19):1985\u201391. https:\/\/doi.org\/10.1056\/NEJMoa043160.","journal-title":"N Engl J Med"},{"issue":"3","key":"689_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","volume":"85","author":"R Steinfeld","year":"2009","unstructured":"Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, Grosso S, G\u00e4rtner J. Folate receptor alpha defect causes cerebral folate transport deficiency: A treatable neurodegenerative disorder associated with disturbed Myelin metabolism. Am J Hum Genet. 2009;85(3):354\u201363. https:\/\/doi.org\/10.1016\/j.ajhg.2009.08.005.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"689_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/jpm11080710","volume":"11","author":"N Bobrowski-Khoury","year":"2021","unstructured":"Bobrowski-Khoury N, Ramaekers VT, Sequeira JM, Quadros EV. Folate receptor alpha autoantibodies in autism spectrum disorders: diagnosis, treatment and prevention. J Pers Med. 2021;11(8):710. https:\/\/doi.org\/10.3390\/jpm11080710.","journal-title":"J Pers Med"},{"issue":"6","key":"689_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-2008-1065354","volume":"38","author":"VT Ramaekers","year":"2007","unstructured":"Ramaekers VT, Blau N, Sequeira JM, Nassogne M-C, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in Low-Functioning autism with neurological deficits. Neuropediatrics. 2007;38(6):276\u201381. https:\/\/doi.org\/10.1055\/s-2008-1065354.","journal-title":"Neuropediatrics"},{"issue":"11","key":"689_CR19","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/acs.molpharmaceut.7b00572","volume":"14","author":"C Alam","year":"2017","unstructured":"Alam C, Hoque MT, Finnell RH, Goldman ID, Bendayan R. Regulation of reduced folate carrier (RFC) by vitamin D receptor at the blood-brain barrier. Mol Pharm. 2017;14(11):3848\u201358. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00572.","journal-title":"Mol Pharm"},{"key":"689_CR20","doi-asserted-by":"publisher","unstructured":"Alam C, Aufreiter S, Georgiou CJ, Hoque MT, Finnell RH, O\u2019Connor DL, Goldman ID, Bendayan R. Upregulation of reduced folate carrier by Vitamin D enhances brain folate uptake in mice lacking folate receptor alpha. Proc Natl Acad Sci U S A. 2019;116(35):17531\u201317540.https:\/\/doi.org\/10.1073\/pnas.1907077116","DOI":"10.1073\/pnas.1907077116"},{"issue":"8","key":"689_CR21","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1096\/fj.202000239RR","volume":"34","author":"C Alam","year":"2020","unstructured":"Alam C, Hoque MT, Sangha V, Bendayan R. Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the Blood-Brain barrier. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2020;34(8):10516\u201330. https:\/\/doi.org\/10.1096\/fj.202000239RR.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"1","key":"689_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12987-022-00391-3","volume":"19","author":"V Sangha","year":"2022","unstructured":"Sangha V, Hoque MT, Henderson JT, Bendayan R. Novel localization of folate transport systems in the murine central nervous system. Fluids Barriers CNS. 2022;19(1):92. https:\/\/doi.org\/10.1186\/s12987-022-00391-3.","journal-title":"Fluids Barriers CNS"},{"key":"689_CR23","first-page":"22","volume-title":"Pathology and genetics: cerebrovascular diseases","author":"S Nag","year":"2005","unstructured":"Nag S, David J. Blood brain barrier, exchange of metabolites and gases. In: Kalimo H, editor. Pathology and genetics: cerebrovascular diseases. Basel: ISN Neuropath; 2005. pp. 22\u20139."},{"issue":"1","key":"689_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo LA. Blood\u2013Brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"689_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The Blood\u2013Brain barrier: structure, regulation and drug delivery. Sig Transduct Target Ther. 2023;8(1):1\u201327. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"689_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte-Endothelial interactions at the Blood-Brain barrier. Nat Rev Neurosci. 2006;7(1):41\u201353. https:\/\/doi.org\/10.1038\/nrn1824.","journal-title":"Nat Rev Neurosci"},{"issue":"7323","key":"689_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C. Pericytes regulate the Blood-Brain barrier. Nature. 2010;468(7323):557\u201361. https:\/\/doi.org\/10.1038\/nature09522.","journal-title":"Nature"},{"issue":"3","key":"689_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","volume":"1778","author":"A Hartsock","year":"2008","unstructured":"Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778(3):660\u20139. https:\/\/doi.org\/10.1016\/j.bbamem.2007.07.012.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"689_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12031-011-9496-4","volume":"44","author":"H Jiao","year":"2011","unstructured":"Jiao H, Wang Z, Liu Y, Wang P, Xue Y. Specific role of tight junction proteins Claudin-5, occludin, and ZO-1 of the Blood-Brain barrier in a focal cerebral ischemic insult. J Mol Neurosci. 2011;44(2):130\u20139. https:\/\/doi.org\/10.1007\/s12031-011-9496-4.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"689_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","volume":"16","author":"C Greene","year":"2019","unstructured":"Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019;16(1):3. https:\/\/doi.org\/10.1186\/s12987-019-0123-z.","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"689_CR31","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1096\/fj.02-0121fje","volume":"16","author":"AS Fanning","year":"2002","unstructured":"Fanning AS, Ma TY, Anderson JM. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J. 2002;16(13):1835\u20137. https:\/\/doi.org\/10.1096\/fj.02-0121fje.","journal-title":"FASEB J"},{"issue":"4","key":"689_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.201412147","volume":"209","author":"S Tietz","year":"2015","unstructured":"Tietz S, Engelhardt B. Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol. 2015;209(4):493\u2013506. https:\/\/doi.org\/10.1083\/jcb.201412147.","journal-title":"J Cell Biol"},{"issue":"4","key":"689_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0031-6997(24)01513-8","volume":"53","author":"G Lee","year":"2001","unstructured":"Lee G, Dallas S, Hong M, Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev. 2001;53(4):569\u201396.","journal-title":"Pharmacol Rev"},{"key":"689_CR34","doi-asserted-by":"publisher","unstructured":"Morris ME, Rodriguez-Cruz V, Felmlee MA, SLC, Transporters ABC. Expression, localization, and species differences at the Blood-Brain and the Blood-Cerebrospinal fluid barriers. AAPS J. 2017;19(5):1317\u201331. https:\/\/doi.org\/10.1208\/s12248-017-0110-8.","DOI":"10.1208\/s12248-017-0110-8"},{"issue":"2","key":"689_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/08916930601183522","volume":"40","author":"J Correale","year":"2007","unstructured":"Correale J, Villa A. The Blood-Brain-Barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity. 2007;40(2):148\u201360. https:\/\/doi.org\/10.1080\/08916930601183522.","journal-title":"Autoimmunity"},{"issue":"12","key":"689_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723\u201338. https:\/\/doi.org\/10.1038\/nrn3114.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"689_CR37","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2011-02-338269","volume":"118","author":"RS Beard","year":"2011","unstructured":"Beard RS, Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the Blood-Brain barrier by NMDA Receptor-Dependent regulation of adherens and tight junctions. Blood. 2011;118(7):2007\u201314. https:\/\/doi.org\/10.1182\/blood-2011-02-338269.","journal-title":"Blood"},{"issue":"7","key":"689_CR38","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1111\/jcmm.14368","volume":"23","author":"M Cheng","year":"2019","unstructured":"Cheng M, Yang L, Dong Z, Wang M, Sun Y, Liu H, Wang X, Sai N, Huang G, Zhang X. Folic acid deficiency enhanced microglial immune response via the Notch1\/Nuclear factor kappa B P65 pathway in Hippocampus following rat brain I\/R injury and BV2 cells. J Cell Mol Med. 2019;23(7):4795\u2013807. https:\/\/doi.org\/10.1111\/jcmm.14368.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"689_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/S0007114507666410","volume":"97","author":"C-M Chang","year":"2007","unstructured":"Chang C-M, Yu C-C, Lu H-T, Chou Y-F, Huang R-FS. Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr. 2007;97(5):855\u201363. https:\/\/doi.org\/10.1017\/S0007114507666410.","journal-title":"Br J Nutr"},{"issue":"8","key":"689_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0753-3322(01)00095-6","volume":"55","author":"C-L Chern","year":"2001","unstructured":"Chern C-L, Huang R-FS, Chen Y-H, Cheng J-T, Liu T-Z. Folate Deficiency-Induced oxidative stress and apoptosis are mediated via Homocysteine-Dependent overproduction of hydrogen peroxide and enhanced activation of NF-\u03baB in human hep G2 cells. Biomed Pharmacother. 2001;55(8):434\u201342. https:\/\/doi.org\/10.1016\/S0753-3322(01)00095-6.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"689_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17(4):389\u2013401. https:\/\/doi.org\/10.1038\/mp.2011.165.","journal-title":"Mol Psychiatry"},{"issue":"11","key":"689_CR42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.drudis.2015.07.002","volume":"20","author":"A Ormazabal","year":"2015","unstructured":"Ormazabal A, Casado M, Molero-Luis M, Montoya J, Rahman S, Aylett S-B, Hargreaves I, Heales S, Artuch R. Can folic acid have a role in mitochondrial disorders?? Drug Discov Today. 2015;20(11):1349\u201354. https:\/\/doi.org\/10.1016\/j.drudis.2015.07.002.","journal-title":"Drug Discov Today"},{"issue":"1","key":"689_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12987-023-00488-3","volume":"20","author":"V Sangha","year":"2023","unstructured":"Sangha V, Aboulhassane S, Qu QR, Bendayan R. Protective effects of pyrroloquinoline Quinone in brain folate deficiency. Fluids Barriers CNS. 2023;20(1):84. https:\/\/doi.org\/10.1186\/s12987-023-00488-3.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"689_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41401-020-0487-2","volume":"42","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Chen J, Guo H, Lu J-L, Zhou J, Guo X-Y, Shi Y, Zhang Y, Yu S, Zhang Q, Ding F. Pyrroloquinoline Quinone promotes mitochondrial biogenesis in Rotenone-Induced parkinson\u2019s disease model via AMPK activation. Acta Pharmacol Sin. 2021;42(5):665\u201378. https:\/\/doi.org\/10.1038\/s41401-020-0487-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"689_CR45","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/biom11101441","volume":"11","author":"KR Jonscher","year":"2021","unstructured":"Jonscher KR, Chowanadisai W, Rucker RB. Pyrroloquinoline-Quinone is more than an antioxidant: A Vitamin-like accessory factor important in health and disease prevention. Biomolecules. 2021;11(10):1441. https:\/\/doi.org\/10.3390\/biom11101441.","journal-title":"Biomolecules"},{"issue":"19","key":"689_CR46","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.3390\/molecules25194359","volume":"25","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Zhou J, Shen M, Xu H, Yu S, Cheng Q, Ding F. Pyrroloquinoline Quinone inhibits Rotenone-Induced microglia inflammation by enhancing autophagy. Molecules. 2020;25(19):4359. https:\/\/doi.org\/10.3390\/molecules25194359.","journal-title":"Molecules"},{"key":"689_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40104-021-00595-x","volume":"12","author":"C Huang","year":"2021","unstructured":"Huang C, Fan Z, Han D, Johnston LJ, Ma X, Wang F. Pyrroloquinoline Quinone regulates the redox status in vitro and in vivo of weaned pigs via the Nrf2\/HO-1 pathway. J Anim Sci Biotechnol. 2021;12:77. https:\/\/doi.org\/10.1186\/s40104-021-00595-x.","journal-title":"J Anim Sci Biotechnol"},{"issue":"10","key":"689_CR48","doi-asserted-by":"publisher","first-page":"e109502","DOI":"10.1371\/journal.pone.0109502","volume":"9","author":"C Yang","year":"2014","unstructured":"Yang C, Yu L, Kong L, Ma R, Zhang J, Zhu Q, Zhu J, Hao D. Pyrroloquinoline Quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-\u03baB and P38\/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment mice. PLoS ONE. 2014;9(10):e109502. https:\/\/doi.org\/10.1371\/journal.pone.0109502.","journal-title":"PLoS ONE"},{"issue":"1","key":"689_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3164\/jcbn.2008005","volume":"42","author":"K Ohwada","year":"2008","unstructured":"Ohwada K, Takeda H, Yamazaki M, Isogai H, Nakano M, Shimomura M, Fukui K, Urano S. Pyrroloquinoline Quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J Clin Biochem Nutr. 2008;42(1):29\u201334. https:\/\/doi.org\/10.3164\/jcbn.2008005.","journal-title":"J Clin Biochem Nutr"},{"issue":"7","key":"689_CR50","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10571-015-0187-5","volume":"35","author":"H Lu","year":"2015","unstructured":"Lu H, Shen J, Song X, Ge J, Cai R, Dai A, Jiang Z. Protective effect of pyrroloquinoline Quinone (PQQ) in rat model of intracerebral hemorrhage. Cell Mol Neurobiol. 2015;35(7):921\u201330. https:\/\/doi.org\/10.1007\/s10571-015-0187-5.","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"689_CR51","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1096\/fj.201600906R","volume":"31","author":"KR Jonscher","year":"2017","unstructured":"Jonscher KR, Stewart MS, Alfonso-Garcia A, DeFelice BC, Wang XX, Luo Y, Levi M, Heerwagen MJR, Janssen RC, de la Houssaye BA, Wiitala E, Florey G, Jonscher RL, Potma EO, Fiehn O, Friedman JE. Early PQQ supplementation has persistent Long-Term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 2017;31(4):1434\u201348. https:\/\/doi.org\/10.1096\/fj.201600906R.","journal-title":"FASEB J"},{"key":"689_CR52","doi-asserted-by":"publisher","unstructured":"Chan GNY, Cannon RE. Assessment of ex vivo transport function in isolated rodent brain capillaries. Curr Protocols Pharmacol. 2017;76(1). https:\/\/doi.org\/10.1002\/cpph.21. 7.16.1\u20137.16.16.","DOI":"10.1002\/cpph.21"},{"issue":"6","key":"689_CR53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/jnc.13389","volume":"135","author":"MT Hoque","year":"2015","unstructured":"Hoque MT, Shah A, More V, Miller DS, Bendayan R. In vivo and ex vivo regulation of breast Cancer resistant protein (Bcrp) by peroxisome Proliferator-Activated receptor alpha (Ppar\u03b1) at the Blood-Brain barrier. J Neurochem. 2015;135(6):1113\u201322. https:\/\/doi.org\/10.1111\/jnc.13389.","journal-title":"J Neurochem"},{"key":"689_CR54","doi-asserted-by":"crossref","unstructured":"Huang C, Hoque T, Bendayan R. Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate Blood-Brain barrier integrity and function. Front Pharmacol 2023, 14.","DOI":"10.3389\/fphar.2023.1118580"},{"issue":"7","key":"689_CR55","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1177\/0271678X16647739","volume":"36","author":"M Roszkowski","year":"2016","unstructured":"Roszkowski M, Bohacek J. Stress does not increase Blood-Brain barrier permeability in mice. J Cereb Blood Flow Metab. 2016;36(7):1304\u201315. https:\/\/doi.org\/10.1177\/0271678X16647739.","journal-title":"J Cereb Blood Flow Metab"},{"key":"689_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biocel.2016.08.040","volume":"79","author":"Y Yang","year":"2016","unstructured":"Yang Y, Li X, Sun Q, He B, Jia Y, Cai D, Zhao R. Folate deprivation induces cell cycle arrest at G0\/G1 phase and apoptosis in hippocampal neuron cells through down-Regulation of IGF-1 signaling pathway. Int J Biochem Cell Biol. 2016;79:222\u201330. https:\/\/doi.org\/10.1016\/j.biocel.2016.08.040.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"689_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12987-024-00566-0","volume":"21","author":"V Sangha","year":"2024","unstructured":"Sangha V, Aboulhassane S, Bendayan R. Regulation of folate transport at the mouse arachnoid barrier. Fluids Barriers CNS. 2024;21(1):67. https:\/\/doi.org\/10.1186\/s12987-024-00566-0.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"689_CR58","doi-asserted-by":"publisher","first-page":"e0152249","DOI":"10.1371\/journal.pone.0152249","volume":"11","author":"JM Sequeira","year":"2016","unstructured":"Sequeira JM, Desai A, Berrocal-Zaragoza MI, Murphy MM, Fernandez-Ballart JD, Quadros EV. Exposure to folate receptor alpha antibodies during gestation and weaning leads to severe behavioral deficits in rats: A pilot study. PLoS ONE. 2016;11(3):e0152249. https:\/\/doi.org\/10.1371\/journal.pone.0152249.","journal-title":"PLoS ONE"},{"key":"689_CR59","doi-asserted-by":"publisher","first-page":"137264","DOI":"10.1016\/j.neulet.2023.137264","volume":"807","author":"A Shaikh","year":"2023","unstructured":"Shaikh A, Roy H. Folate deprivation induced neuroinflammation impairs cognition. Neurosci Lett. 2023;807:137264. https:\/\/doi.org\/10.1016\/j.neulet.2023.137264.","journal-title":"Neurosci Lett"},{"issue":"1","key":"689_CR60","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1074\/jbc.M109.030130","volume":"285","author":"W Chowanadisai","year":"2010","unstructured":"Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline Quinone stimulates mitochondrial biogenesis through cAMP response Element-Binding protein phosphorylation and increased PGC-1\u03b1 expression. J Biol Chem. 2010;285(1):142\u201352. https:\/\/doi.org\/10.1074\/jbc.M109.030130.","journal-title":"J Biol Chem"},{"issue":"1","key":"689_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-023-01642-6","volume":"11","author":"A Canovai","year":"2023","unstructured":"Canovai A, Tribble JR, J\u00f6e M, Westerlund DY, Amato R, Trounce IA, Dal Monte M, Williams PA. Pyrroloquinoline Quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection. Acta Neuropathol Commun. 2023;11(1):146. https:\/\/doi.org\/10.1186\/s40478-023-01642-6.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"689_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00284-014-0607-7","volume":"69","author":"J Sun","year":"2014","unstructured":"Sun J, Han Z, Ge X, Tian P. Distinct promoters affect pyrroloquinoline Quinone production in Recombinant Escherichia Coli and Klebsiella Pneumoniae. Curr Microbiol. 2014;69(4):451\u20136. https:\/\/doi.org\/10.1007\/s00284-014-0607-7.","journal-title":"Curr Microbiol"},{"issue":"1","key":"689_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-019-1689-8","volume":"17","author":"B Haileselassie","year":"2020","unstructured":"Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D. Mitochondrial dysfunction mediated through Dynamin-Related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy. J Neuroinflamm. 2020;17(1):36. https:\/\/doi.org\/10.1186\/s12974-019-1689-8.","journal-title":"J Neuroinflamm"},{"issue":"Pt","key":"689_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neubiorev.2014.01.012","volume":"46","author":"D Valenti","year":"2014","unstructured":"Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual Disability-Related diseases: an overview of down syndrome, autism, fragile X and Rett syndrome. Neurosci Biobehav Rev. 2014;46(Pt):202\u201317. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.01.012.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"689_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Sig Transduct Target Ther. 2017;2(1):1\u20139. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Sig Transduct Target Ther"},{"issue":"9","key":"689_CR66","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/jnr.21647","volume":"86","author":"IK Hwang","year":"2008","unstructured":"Hwang IK, Yoo K-Y, Suh H-W, Kim YS, Kwon DY, Kwon Y-G, Yoo J-H, Won M-H. Folic acid deficiency increases delayed neuronal death, DNA damage, platelet endothelial cell adhesion Molecule-1 immunoreactivity, and gliosis in the Hippocampus after transient cerebral ischemia. J Neurosci Res. 2008;86(9):2003\u201315. https:\/\/doi.org\/10.1002\/jnr.21647.","journal-title":"J Neurosci Res"},{"key":"689_CR67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","volume":"21","author":"T Chen","year":"2024","unstructured":"Chen T, Dai Y, Hu C, Lin Z, Wang S, Yang J, Zeng L, Li S, Li W. Cellular and molecular mechanisms of the Blood\u2013Brain barrier dysfunction in neurodegenerative diseases. Fluids Barriers CNS. 2024;21:60. https:\/\/doi.org\/10.1186\/s12987-024-00557-1.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"689_CR68","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1038\/s41598-018-26962-9","volume":"8","author":"X-Q Zhou","year":"2018","unstructured":"Zhou X-Q, Yao Z-W, Peng Y, Mao S-S, Xu D, Qin X-F, Zhang R-J. PQQ ameliorates D-Galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3\u03b2\/Akt signaling pathway in mouse. Sci Rep. 2018;8(1):8894. https:\/\/doi.org\/10.1038\/s41598-018-26962-9.","journal-title":"Sci Rep"},{"key":"689_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.intimp.2019.04.040","volume":"72","author":"Z Wang","year":"2019","unstructured":"Wang Z, Han N, Zhao K, Li Y, Chi Y, Wang B. Protective effects of pyrroloquinoline quinine against oxidative Stress-Induced cellular senescence and inflammation in human renal tubular epithelial cells via Keap1\/Nrf2 signaling pathway. Int Immunopharmacol. 2019;72:445\u201353. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.040.","journal-title":"Int Immunopharmacol"},{"key":"689_CR70","doi-asserted-by":"publisher","unstructured":"Che J, Sun Y, Deng Y, Zhang J, Blood-Brain. Barrier disruption: A culprit of cognitive decline?? Fluids Barriers CNS. 2024;21(1):63. https:\/\/doi.org\/10.1186\/s12987-024-00563-3.","DOI":"10.1186\/s12987-024-00563-3"},{"issue":"2","key":"689_CR71","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1042\/BST20220830","volume":"51","author":"A Patabendige","year":"2023","unstructured":"Patabendige A, Janigro D. The role of the Blood-Brain barrier during neurological disease and infection. Biochem Soc Trans. 2023;51(2):613\u201326. https:\/\/doi.org\/10.1042\/BST20220830.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"689_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jnc.15460","volume":"159","author":"E Gozal","year":"2021","unstructured":"Gozal E, Jagadapillai R, Cai J, Barnes GN. Potential crosstalk between Sonic Hedgehog-Wingless-Related integration site signaling and neurovascular molecules: implications for blood brain barrier integrity in autism spectrum disorder. J Neurochem. 2021;159(1):15\u201328. https:\/\/doi.org\/10.1111\/jnc.15460.","journal-title":"J Neurochem"},{"issue":"3","key":"689_CR73","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1096\/fj.12-218495","volume":"27","author":"X Wang","year":"2013","unstructured":"Wang X, Cabrera RM, Li Y, Miller DS, Finnell RH. Functional regulation of P-Glycoprotein at the Blood-Brain barrier in Proton-Coupled folate transporter (PCFT) mutant mice. FASEB J. 2013;27(3):1167\u201375. https:\/\/doi.org\/10.1096\/fj.12-218495.","journal-title":"FASEB J"},{"key":"689_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/asheducation-2003.1.62","volume":"2003 1","author":"R Carmel","year":"2003","unstructured":"Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology. 2003;2003 1:62\u201381. https:\/\/doi.org\/10.1182\/asheducation-2003.1.62.","journal-title":"Hematology"},{"issue":"2","key":"689_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP. The Blood-Brain barrier\/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173\u201385. https:\/\/doi.org\/10.1124\/pr.57.2.4.","journal-title":"Pharmacol Rev"},{"key":"689_CR76","doi-asserted-by":"publisher","first-page":"115272","DOI":"10.1016\/j.biopha.2023.115272","volume":"165","author":"X Zheng","year":"2023","unstructured":"Zheng X, Ren B, Gao Y. Tight junction proteins related to Blood-Brain barrier and their regulatory signaling pathways in ischemic stroke. Biomed Pharmacother. 2023;165:115272. https:\/\/doi.org\/10.1016\/j.biopha.2023.115272.","journal-title":"Biomed Pharmacother"},{"issue":"29","key":"689_CR77","doi-asserted-by":"publisher","first-page":"10677","DOI":"10.1523\/JNEUROSCI.5692-10.2011","volume":"31","author":"M Morin-Brureau","year":"2011","unstructured":"Morin-Brureau M, Lebrun A, Rousset M-C, Fagni L, Bockaert J, Bock F. Epileptiform activity induces vascular remodeling and Zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J Neurosci. 2011;31(29):10677\u201388. https:\/\/doi.org\/10.1523\/JNEUROSCI.5692-10.2011. Lerner-NatoliM.","journal-title":"J Neurosci"},{"issue":"12","key":"689_CR78","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/sj.eye.6702716","volume":"21","author":"YL Wang","year":"2007","unstructured":"Wang YL, Hui YN, Guo B, Ma JX. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving Angiopoietin-1 signal way. Eye. 2007;21(12):1501\u201310. https:\/\/doi.org\/10.1038\/sj.eye.6702716.","journal-title":"Eye"},{"issue":"5","key":"689_CR79","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/bph.12489","volume":"171","author":"S Engelhardt","year":"2014","unstructured":"Engelhardt S, Patkar S, Ogunshola OO. Cell-Specific Blood\u2013Brain barrier regulation in health and disease: A focus on hypoxia. Br J Pharmacol. 2014;171(5):1210. https:\/\/doi.org\/10.1111\/bph.12489.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"689_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2006.09.010","volume":"411","author":"BT Hawkins","year":"2007","unstructured":"Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD. Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats. Neurosci Lett. 2007;411(1):1\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2006.09.010.","journal-title":"Neurosci Lett"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00689-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:06:06Z","timestamp":1757268366000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00689-y","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}